Literature DB >> 6294212

Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin production by human B cells.

R Yarchoan, G Tosato, R M Blaese, R M Simon, D L Nelson.   

Abstract

The Epstein-Barr virus (EBV) is a herpes virus that has the capacity to infect human B cells and to induce them to secrete immunoglobulin (Ig). In the current experiments, Poisson analysis of limiting dilution cultures has been used to study the activation of human peripheral B cells by the B95-8 strain of EBV. Under the culture conditions used, 0.2-1% of peripheral blood B cells were activated by EBV to secrete IgM or IgG. In addition, when multiple replicate cultures containing limited numbers of B cells were tested for IgM and for IgG production, the precursors for IgM and IgG segregated independently; thus, individual B cell precursors matured into cells secreting IgM or IgG but not both classes of Ig. Additional experiments using limiting dilutions of EBV were undertaken to study the viral requirements for B cell activation. These studies indicated that B cell activation by EBV to produce Ig was consistent with a "one-hit" model and inconsistent with a "two-hit" model. Taken together, these results indicate that infection by one EBV virion is sufficient to induce a precursor peripheral blood B cell to secrete Ig and that only one isotype of Ig is then secreted.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6294212      PMCID: PMC2186914          DOI: 10.1084/jem.157.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

Review 1.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children.

Authors:  A J Provisor; J J Iacuone; R R Chilcote; R G Neiburger; F G Crussi
Journal:  N Engl J Med       Date:  1975-07-10       Impact factor: 91.245

3.  Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.

Authors:  M F Greaves; G Brown
Journal:  Clin Immunol Immunopathol       Date:  1975-03

4.  Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes.

Authors:  C M Steel; J Philipson; E Arthur; S E Gardiner; M S Newton; R V McIntosh
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

Review 5.  Herpesviruses and oncogenesis.

Authors:  G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

6.  A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo.

Authors:  K E Hopper; C L Geczy; W A Davies
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Human T-cell subset requirements for the production of specific anti-influenza virus antibody in vitro.

Authors:  R Yarchoan; W E Biddison; H S Schneider; D L Nelson
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Immunoglobulin isotype expression. II. Frequency analysis in mitogen-reactive B cells.

Authors:  R Benner; A Coutinho; A M Rijnbeek; A van Oudenaren; H Hooijkaas
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

9.  Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors:  W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal:  Science       Date:  1967-09-01       Impact factor: 47.728

10.  Characteristics of Epstein-Barr virus activation of human B lymphocytes.

Authors:  A G Bird; S Britton; I Ernberg; K Nilsson
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  35 in total

1.  Epstein-Barr virus transformation of Saimiri sciureus (squirrel monkey) B cells and generation of a Plasmodium brasilianum-specific monoclonal antibody in P. brasilianum-infected monkeys.

Authors:  C Chizzolini; A J Sulzer; M A Olsen-Rasmussen; W E Collins
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

2.  Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.

Authors:  J A Tooze; D H Bevan
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

3.  In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.

Authors:  T Hibi; M Ohara; K Toda; A Hara; H Ogata; Y Iwao; N Watanabe; M Watanabe; Y Hamada; K Kobayashi
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

4.  Light-chain gene expression before heavy-chain gene rearrangement in pre-B cells transformed by Epstein-Barr virus.

Authors:  H Kubagawa; M D Cooper; A J Carroll; P D Burrows
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 5.  B cell clones in rheumatoid arthritis.

Authors:  M Steinitz
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Immunoglobulin gene rearrangements and deletions in human Epstein-Barr virus-transformed cell lines producing different IgG and IgA subclasses.

Authors:  C F Webb; M D Cooper; P D Burrows; J A Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.

Authors:  G Tosato; A D Steinberg; R Yarchoan; C A Heilman; S E Pike; V De Seau; R M Blaese
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

8.  Studies of the expression of the Wiskott-Aldrich syndrome protein.

Authors:  D M Stewart; S Treiber-Held; C C Kurman; F Facchetti; L D Notarangelo; D L Nelson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.

Authors:  M M Newkirk; J Rauch
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 10.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.